Bonit Capital, Swedish family-owned investment company

12th June 2021

Leksell Social Ventures raises 300 MSEK to scale investments and spread innovations in public sector

Laurent Leksell sees new financing models as crucial to making the public sector more innovative. The investment strategy consists of two parts. The first and more traditional is to go in with capital directly in startup companies that tackle societal problems. The second part of the investment strategy, social outcome contracts, or social impact bonds, is a newer concept. In 2016, the company developed Sweden's first social outcome contract in collaboration with the municipality of Norrköping and SKR. "If you want to solve problems, and get 'impact', you have to cooperate and interact with the public sector," says Hugo Mörse - Managing Director of LSV.

Read Full Article

7th June 2021

Elekta and Philips deepen strategic partnership in precise and individualized oncology care

Elekta (EKTA-B.ST) and Royal Philips (NYSE: PHG, AEX: PHIA) today signed agreements to deepen their existing strategic partnership to advance comprehensive and personalized cancer care through precision oncology solutions. The extended collaboration builds on the two companies’ successful cooperation in the fast-emerging field of magnetic resonance (MR)-guided adaptive radiation therapy. Through deeper cross-portfolio collaboration, Elekta and Philips will utilize their complementary capabilities to further improve patient care.

Read Full Article

7th June 2021

Elekta's new strategy to focus on growth and access to radiation therapy

At Elekta’s (EKTA-B.ST) Capital Markets Day, CEO, Gustaf Salford, and members from his executive management team introduced the company’s mid-term strategy, called Access 2025. The strategy reflects the work the company will continue to do to pursue the vision of a world where everyone has access to the best cancer care. The Access 2025 strategy is built on four pillars: innovation, partner integration, customer focus and driving adoption of radiation therapy across the globe, reflecting Elekta’s vision to create a world where everyone has access to the best cancer care.

Read Full Article

27th April 2021

Meru Health develops digital mental health support program for employees with anxiety and depression

Looking to prevention, Meru Health, maker of digital mental health tools, is launching a new program aimed at helping employees dealing with mild depression or anxiety symptoms. Last year, Meru Health landed $8.1 million in Series A. The company, which is known for its 12-week mental health coaching program, also launched a biofeedback tool in 2019. The tool is clipped on a user’s ear when they are doing a specific biofeedback practice provided by the Meru Health platform.

Read Full Article

22nd April 2021

Volt Diversified Alpha Fund wins Best Nordic CTA award 2020

The Volt Diversified Alpha Program applies machine learning to financial markets with the aim to deliver capital appreciation in all market conditions. In the Nordic region, there were players in the CTA space that stood out of the crowd and delivered strong gains for investors both in 2020 and over the previous years. Congrats Volt on this prestigious award!

Read Full Article

3rd April 2021

Region Stockholm's Health Impact Bond wins Environmental Finance's Bond Awards 2021

LSV portfolio company Health Integrator & Region Stockholm's Health Immpact Bond wins Social Impact Bond of the year. “We are very honored to receive the award Social project bond of the year. Just as Region Stockholm has played a leading role in the work with green bonds, we also have the ambition of being forward-thinking in the fields of social entrepreneurship and social financing. We have therefore developed a Health Impact Bond, which has a unique financial structure”, said Frida Korneliusson, CEO of Region Stockholm Treasury.

Read Full Article

12th March 2021

Rhenman & Partners wins international fund award at Hedgeweek European Awards: Best Global Hedge Fund

A total of 21,715 industry experts participated in the final voting. Rhenman Healthcare Equity L/S has an unprecedented performance history since its inception in June 2009. The main unit class, IC1 (EUR), has increased by 695 percent in total, which corresponds to an average annual net return of 19 percent. At present, assets under management in the fund amount to approximately USD 1.1 billion.

Read Full Article

16th February 2021

Digital health company OneLab raises SEK 40 million round led by Novax

OneLab offers smart, modern health surveys that help companies map and improve employee health and identify and address any work environment risks. By collecting, analyzing and transforming complex health data into simple and educational reports, we create a valuable foundation for long-term health work. OneLab was founded in 2014 and is today one of the leading companies in preventive occupational health care. We are located in both Sweden and many other European countries.

Read Full Article

8th February 2021

Princeville Climate Tech fund: VOLTA Announces $1.4bn SPAC Merger

"Volta's unique business model is poised to capture the vast consumer spending shifts that will accompany our society's shift from carbon to electric," said Scott Mercer, Founder and CEO of Volta. "With the shift to electric mobility, consumers will expect to fuel where they go. Volta will anchor the infrastructure change, transforming fueling locations away from standalone gas stations to high traffic locations in the community where consumers live, work, and play."

Read Full Article

14th January 2021

AI - Personalized Learning Sana Labs raises $18m Series A led by EQT Ventures

Leksell Social Ventures portfolio company Sana Labs raises $18m led by EQT Ventures. The vision is to personalize learning for everyone. Since founding, Sana has helped hundreds of thousands of learners, with 98% reporting that Sana improved their learning. Our Series A will allow the company to amplify our efforts for reimagining how learning is delivered, created, and analyzed. The goal is to take Sana to hundreds of millions of people around the world.

Read Full Article

22th October 2020

Brain health platform Mindmore is the winner of Di Digital's Health Tech Pitch Day 2020

Leksell Social Ventures portfolio company Mindmore is the winner of Di Digital's Health Tech Pitch Day 2020. Mindmore's digital platform makes it easier to test patients against dementia and depression. Mindmore is now in the starting blocks to take the next step in the fight for better brain health. Congratulations Sara and team!

Read Full Article

15th October 2020

Richard Leksell "Our ambition is to become one of the leading healthcare investors in the Nordics"

Life Science Sweden has interviewed Richard Leksell, partner and responsible for direct investments at Bonit Capital. How does Bonit Capital think about its investments in digital health, diagnostics and medical technology?

Read Full Article

19th July 2020

Bonit Capital Leads Seed Investment in Search & Booking Healthcare Platform Vården.se

Sweden's largest marketplace for search and booking healthcare is making its first capital raising led by Bonit Capital. "The healthcare sector is facing major challenges. We must use digital tools and e-health to support the Swedish healthcare system. Vården.se is a key player in this transformation and we look forward to supporting the company to become a leading player in search and booking of care in Sweden and internationally, says Richard Leksell, partner at Bonit Capital.

Read Full Article

16th June 2020

Leksell Social Ventures Invests in Preventive Care and the First Health Impact Bond in Sweden

Health Integrator is an important investment for us as the company offers both the public sector, corporate health, and the individual a way to finance and customize preventive health. A measurable solution to a prioritized social problem and a system change in how society thinks about health, says Hugo Mörse, CEO of Leksell Social Ventures.

Read Full Article

4th June 2020

Immunovia has Raised MSEK 400 to Accelerate Commercialization Start for IMMray™ PanCan-d

The proceeds from the Directed Issue are intended to finance the Company’s investments in an accelerated commercialization start for IMMray™ PanCan-d. In addition to strong support from existing and new local investors, the Company also attracted sizeable amounts from international investors who participated thus further broadening its shareholder base.

Read Full Article

15th May 2020

Affibody and Inmagene Announce Strategic Partnership to Develop Drug Candidate for Auto-Immune Diseases

Under the terms of the agreement, Affibody will receive a $10 million upfront payment and is eligible to receive up to $215.5 million in additional regulatory and sales milestones, plus royalties on sales in Inmagene’s commercialization territory.

Read Full Article

12th May 2020

Meru Health raises $8.1 million Series A to increase access to mental health therapy

With surging demand for mental health counselling, Meru Health has raised $8.1 million to offer virtual therapy. Venture capital firm Foundry Group led the funding. Workplace productivity firm Slack and Bold Capital also joined the funding round.

Read Full Article

31st March 2020

Leksell Social Ventures och Sana Labs effektiviserar SFI med AI - vill halvera tiden

Leksell Social Ventures och Sana Labs samarbetar för att lansera en ny SFI-utbildning baserad på AI-teknik. Leksell Social Ventures har länge engagerat sig i integrationsfrågor och en frågeställning som investeringsbolaget haft är hur de kan bidra till att förbättra det svenska SFI-systemet.

Read Full Article

29th January 2020

Sysmex Invests in Astrego Diagnostics to support commercialization phase

Sysmex aims to help commercialize a rapid drug susceptibility test that Astrego is developing for urinary tract infections. Urinary tract infections are infectious diseases with a high rate of incidence and are said to affect 150 million people globally. With this investment, Sysmex acquired 24.99% of Astrego’s shares.

Read Full Article

23rd January 2020

Bonit Capital Leads Seed Investment in Healthcare Staffing Platform Medpeople.se

Genom att lösa sjukvårdens korta, oförutsägbara, vakanser hoppas medtech-bolaget Medpeople kunna lösa ett större problem med långa vakanser inom sjukvården. Med en app där vårdpersonal kan välja bland olika uppdrag vill bolaget hitta extern bemanning till sjukvården, utan att den ska behöva använda sig av långa konsultuppdrag.

Read Full Article

25th November 2019

Bonit Capital invests in Princeville Climate Technology Fund

The new $300m fund invests in technology companies that are benefiting from and supporting the global transition to lower carbon economies and that have a fundamental Climate Positive™ impact. By targeting both financial returns and impact, the firm aims to attract more capital into this rapidly growing sector and to contribute to the critical need for investment into near-term climate solutions.

Read Full Article

6th June 2019

Elekta wins 2019 "Medical Device Engineering Breakthrough" award from MedTech Breakthrough

MedTech Breakthrough, an independent organization that recognizes the top companies and solutions in the global health and medical technology market, has presented the “Medical Device Engineering Breakthrough” award in the 2019 MedTech Breakthrough Awards program to Elekta for its Elekta Unity MR-linac.

Read Full Article

3rd June 2019

Immunovia announces excellent results across all symptomatic risk groups from IMMray™ PanCan-d optimization work

This is a major breakthrough in the global quest for a reliable non-invasive blood test for early detection of cancer. IMMray™ PanCan-d blood-based test for early detection of pancreatic cancer now set for Q3 2020 launch.

Read Full Article

1st June 2019

Leksell Social Ventures har genomfört 3 nya direktinvesteringar & lanserat Social Innovation Podcast

LSV har genomfört tre nya direktinvesteringar - Sana Labs, Meru Health och Just Arrived. Utbildning, psykisk hälsa och integration fortsätter vara fokusområden för LSV.

Read Full Article

29th May 2019

Strålknivbolaget Elekta slår förväntningarna - aktien rusar

Strålterapibolaget Elekta redovisar ett ebita-resultat på 985 miljoner kronor för det fjärde kvartalet i sitt brutna räkenskapsår.

Read Full Article

25th April 2019

Digital mental health platform Meru Health snags $4.2M in seed funding

This morning, Finland and Palo Alto-based Meru Health, maker of a mental health platform, landed $4.2 million in seed funding. The new money comes from Freestyle Capital, Bonit Capital, Y Combinator, Lifeline Ventures and IT-Farm.

Read Full Article

24th April 2019

Guldregn över svensk hjärtmonitor Coala Life – storsatsar på USA

Nyligen fick det svenska medicinteknikbolaget Coala Life sin hjärtmonitor FDA-godkänd. Nu tar man in 92 miljoner kronor i riskkapital och siktar på en snabbexpansion i USA.

Read Full Article

30th January 2019

It-profilernas Monterro stänger ny miljardfond

Monterro vill ta fler svenska mjukvarubolag ut i världen. Nu har riskkapitalbolaget fyllt på en ny fond med 2,5 miljarder kronor. ”Vi tycker att det är en fördel att vara snäva”, säger grundaren Thomas Bill.

Read Full Article

18th January 2019

ScientificMed vill effektivisera cancerbehandlingar – backas av tunga investerare

Nu tar ScientificMed in 10 miljoner kronor för att snabba på utvecklingen och satsa internationellt. Bonit Capital leder rundan. Det är familjen Leksells (som även är huvudägare i medicinteknikbolaget Elekta) investmentbolag.

Read Full Article

5th July 2018

Norrköping kommun är först ut i Sverige att prova ett socialt utfallskontrakt tillsammans med Leksell Social Ventures

I Norrköping ska en privat investering minska antalet återplacerade ungdomar på HVB-hem. Sociala utfallsmodellen bygger på ett kontrakt som ”vänder uppochner på allt vi sagt om privat välfärd”, enligt det socialdemokratiska kommunalrådet, tidigare partisekreteraren Lars Stjernkvist.

Read Full Article

13th March 2018

Elektagrundaren: ”Livet är allvarligt, men sällan desperat”

”Hur kommer det sig att pucken hamnade där du inte vill att den ska eller borde ligga?” Den frågan ställer Elektagrundaren Larry Leksell under Di:s intervju om boken ”Strålande tider: Hur jag gjorde Elekta till ett världsföretag”.

Read Full Article